Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections.

PHASE4RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

March 10, 2020

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Herpes Simplex
Interventions
DRUG

2LHERP®

The treatment schema consists in taking the content of one capsule a day, 15-30 minutes before breakfast, on an empty stomach, sequentially, according to capsules' numerical order: 1 through 10. When capsule number 10 is taken, capsule 1 of the next blister should be taken on the next day to continue the treatment. The duration of treatment will be 6 months of continuous intake of the content of 1 capsule/day.

DRUG

Placebo

The treatment schema consists in taking the content of one capsule a day, 15-30 minutes before breakfast, on an empty stomach, sequentially, according to capsules' numerical order: 1 through 10. When capsule number 10 is taken, capsule 1 of the next blister should be taken on the next day to continue the treatment. The duration of treatment will be 6 months of continuous intake of the content of 1 capsule/day.

Trial Locations (6)

1480

RECRUITING

Private Practice, Oisquercq

1630

RECRUITING

Private Practice, Linkebeek

1650

RECRUITING

Private Practice, Beerzel

5004

RECRUITING

Clinique Saint-Luc (Bouge), Bouge

5030

RECRUITING

Cabinet privé, Beuzet

6831

RECRUITING

Cabinet privé, Noirefontaine

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Labo'Life

INDUSTRY